Volpara Health Technologies Limited


Transaction Type: Scheme of arrangement

Offeror / Other Party: Lunit Inc.

Independent Adviser(s): Grant Samuel & Associates Limited

Date of meeting: 12/04/2024


On 14 December 2023, Volpara Health Technologies Limited (Volpara), an ASX-listed New Zealand registered company, and Lunit Inc. (Lunit) entered into a scheme implementation agreement under which Lunit would acquire 100% of the fully paid ordinary shares in Volpara for consideration of $1.15 AUD per share.


On 12 April 2024, Volpara shareholders voted to approve the scheme. The High Court granted final orders on 3 May 2024. The scheme was implemented on 21 May 2024 and Volpara was delisted from the ASX on 22 May 2024.


Grant Samuel & Associates Limited prepared the independent adviser’s report on the merits of the transaction.